Skip to main content
Clinical Trials/TCTR20230321010
TCTR20230321010
Completed
Phase 1

Effectiveness of a phone-based support program on self-care self-efficacy, psychological well-being, and quality of life among women newly diagnosed with breast cancer undergoing chemotherapy: a randomized controlled trial

/A0 sites94 target enrollmentMarch 21, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
A singled-blinded randomized controlled trial (RCT), pretest-posttest design technique was used to examine the effectiveness of the phone-based support program (PBSP) among women newly diagnosed with breast cancer undergoing chemotherapy.
Sponsor
/A
Enrollment
94
Status
Completed
Last Updated
last year

Overview

Brief Summary

The Phone-Based Support Program showed feasibility and effectiveness in improving self-care self-efficacy, reducing symptom distress, and enhancing quality of life.

Registry
who.int
Start Date
March 21, 2023
End Date
July 7, 2023
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • The participants will be recruited through the target population.
  • The inclusion criteria will be:(1\) at least 18 years of age, (2\) newly diagnosed as breast cancer with non\-metastatic or stage II or lower within the past 3\-8 weeks, (3\) treated with chemotherapy after surgery at the study sites, (4\) be able to access the internet with a mobile phone (5\) be contactable via the mobile phone for follow up; and (6\) able to communicate Mandarin.

Exclusion Criteria

  • The exclusion criteria will be: (1\) having a concurrent major physical illness, like any physical surgery except for the surgery treatment for breast cancer, injuries or illnesses with the potential for lifelong disability, advanced chronic illness, profound coma, permanent paralysis, or severe brain injury (2\) having a chronic mental health problem as diagnoses by a psychiatrist, and (3\) unable to complete all session of the implementation.

Outcomes

Primary Outcomes

Not specified

Similar Trials